MTUM iShares MSCI USA Momentum Factor ETF

Expense Ratio
0.15%
Dividend
0.60%
Previous close
$309.32
Est. 12 months change
+21.10%
Projected Price
$374.58

Profitability Metrics

Return on Equity (ROE)
41.01%
Return on Assets (ROA)
11.01%
Return on Invested Capital (ROIC)
27.91%
Weighted Average Cost of Capital (WACC)
10.98%
ROIC - WACC
16.94%
Updated : 2026-08-08 05:26 ET

Valuation Metrics

P/E Ratio
29.89
Forward P/E
19.93
PEG Ratio
1.52
Debt Current Ratio
1.96

Growth & Cash Flow

Gross Margin
48.88%
Operating Margin
26.07%
FCF Margin
19.70%
TTM Revenue Growth
49.74%
Projected 12M EPS Growth
49.93%

Price Change

Price % from 50 SMA
-2.38%
Price % from 200 SMA
13.11%
6 Months
22.02%
1 Year
26.84%
2 Years
75.73%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
MU6.27%
AMD5.22%
AVGO4.72%
INTC4.11%
XOM3.81%
CAT3.64%
JNJ3.54%
LRCX3.15%
AMAT3.08%
GEV3.05%

ETF Analysis

Fund Overview

iShares MSCI USA Momentum Factor ETF (MTUM) currently reports 127 stock positions (subject to change), placing it in the broadly constructed range by holdings breadth. The top line-up is MU (6.27%), AMD (5.22%), AVGO (4.72%), with MU as the largest single weight at 6.27%. Together, the top three holdings account for 16.21%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Profitability & Capital Efficiency

Looking at how effectively the underlying holdings deploy capital, ROIC is 27.91%, WACC is 10.98%, and the economic spread is 16.94%. On balance, returns on invested capital exceed the cost of funding by a comfortable margin, which over time compounds favorably for long-term holders. Supporting metrics show ROE at 41.01% and ROA at 11.01%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

On an earnings multiple basis, trailing P/E of 29.89, forward P/E of 19.93, PEG of 1.52. The spread between trailing and forward P/E is moderate, suggesting some earnings improvement is expected but not a dramatic re-rating. The PEG ratio sits in a range that most investors would consider fair — neither cheap nor obviously stretched relative to anticipated earnings. A current ratio reading of 1.96 points to holdings that are managing short-term obligations without apparent stress. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 48.88%, operating margin at 26.07%, and free cash flow margin at 19.70%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins are in good shape, consistent with businesses that maintain reasonable earnings conversion after overhead. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margin levels suggest a portfolio where earnings durability is present in parts but not consistent across the full holding set.

Growth & Forward Outlook

On a forward-looking basis, TTM revenue growth of 49.74% a signal of strong operational momentum across the holding set, while the estimated 12-month price change of 21.31%, where the target distribution indicates incremental upside rather than outsized repricing. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.